Skip to content

Borregaard stock

BRG.OLOSL

Borregaard ASA, Basic MaterialsISIN NO0010657505

$16.45▼ $0.08 (−0.5%)Closing price of 12 Nov 2026

63Score 63 out of 100, Neutral

Turn on early warning

Price and trend

60 / 100

Price history

−17% in one year

The chart shows daily closes over 14 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.

Long-term trend

Below the 200-day line: the price is 0.7% below it.

Trend change

Since February 2026 the 50-day line has been below the 200-day line; the trend has turned down.

Momentum

Overheated: the price has risen very quickly lately (RSI 74).

Distance to the high

The price is 21% below its 52-week high. Largest decline in 14 years: 47% (August 2021 to October 2022).

Chart figures for advanced users
SMA 50$15.80
Average price of the last 50 trading days, shows the short-term trend.
SMA 200$16.56
Average price of the last 200 trading days, shows the long-term trend.
RSI (14)74
Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
MACDabove the signal line
Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
Support$14.52
The lowest closing price of the last twelve months.
Resistance$20.94
The highest closing price of the last twelve months.
Market cap
$1.64B
Div. yield
3.03%
12 months
58.1
earnings collapsed, on expected earnings 16.6
16.6
on earnings for the next twelve months ($0.99 per share)
Fair value
$28.79

Snapshot

Computed from the data by fixed rules, no AI

  • Borregaard ASA belongs to the Chemicals (Specialty) industry (Norway) and, with a market value of $1.64B, is number 86 of 106 companies in its industry on MEQIRI.
  • In fiscal 2025 it reported revenue of $795.17M (up 1% year on year) and earnings of $65.04M (down 24.7%).
  • For fiscal 2026, analysts expect on average revenue of $820.89M (up 3.2%) and adjusted earnings per share of $0.67.
Show more
  • MEQIRI Score 63 out of 100 (Neutral): rank 155 of 461 in Basic Materials, median 57.
  • The P/E is 58.1 because earnings over the last twelve months collapsed; on the expected earnings of the next twelve months it is 16.6 (Chemicals (Specialty) median 24.4). The P/E therefore does not count in the score.
  • Our model puts fair value at $28.79, with the price 43% below it.

In plain words

The numbers on this page in plain words, written by an AI

Strengths

  • Earnings turn into cashFree cash flow 336% of earnings over the last 12 months.Fundamentals 80
  • Analysts expect strong earnings growthUp 33.5% a year through 2028 (estimates from 5 analysts).
  • Below fair valuePrice 43% below the fair value of $28.79.Valuation 95

Weaknesses

None of our weakness checks flags anything. Crash risk is measured separately.

63/ 100
MEQIRI Score
Neutral

Its standout strengths are valuation and stability, while growth and profitability hold the score back.

Daily figure as of 13 Nov 2026

How the score is calculated

Score overview

Fundamentals are strong, with stable profits and strong cash generation.

Profit consistency100% of years
Cash conversion (free cash flow to earnings, 12 months)336%
ROIC (12 months)8.1%
Positive free cash flow80% of years
How this category is measured

Score history

The full history of up to 20 years comes with MEQIRI Pro.

See plans

Crash risk medium

How well MEQIRI warns

In the middle among smaller stocks.

From 2016 to 2025, 20 in 100 such stocks fell 30% or more within a year, against a group average of 23 in 100.

What drives the risk

  • cyclical sector (energy or materials), as a group, crashed more often in the backtest

What lowers it

  • solid fundamentals
  • calm price action

Valuation

Valuation signal

Significantly undervalued
Price
$16.45
Fair value
$28.79
Gap to fair value
−43%

In our model the price counts as cheap below $22.15 and expensive above $41.13 (uncertainty medium, based on the price swings of the past year).

Calculated with a cost of equity of 8.5%. At 9.5% the fair value would be $23.69, at 7.5% it would be $36.48.

Valuation metrics

2.25
10.7
Fair value (model)
$28.79

From the cash-flow model alone; after a one-off collapse in earnings there is no industry value.

Calculate with your own assumptions

Company performance

This shows several years of history with an automatic assessment.

Revenue

17 years

In the twelve months to 30 Sep 2026, revenue rose 2.9% on the twelve months before. Revenue has grown solidly since 2009, at about 5% per year.

Margins

17 years
  • Gross margin
  • Operating margin
  • Net margin

In fiscal 2025: gross 38%, operating 17%, net 8%.

Debt & balance sheet

latest quarter
0.36
7.3x
1.95
Cash & equivalents
$37.77M

Moderate debt, and interest is adequately covered.

Earnings

Next earnings
3 Feb 2027in 82 days
Last reported
28 Oct 2026EPS reported $0.30 (expected $0.22)above expectations

Analyst estimates

Analysts have cut their 2027 earnings estimate by 3.3% since 15 Oct 2026. Falling estimates often precede bad news.

Fiscal 20265 analysts
Earnings per share
$0.67+12.4%
Revenue
$820.89M−1.3%
Fiscal 20275 analysts
Earnings per share
$1.04−3.3%
Revenue
$861.32M−1.7%

MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.

Company outlook lowered

Share price after the results: +9.5%

Borregaard expects a significantly weaker product mix in Fine Chemicals, notably lower bioethanol deliveries, rising energy and sulfur costs, and the annual maintenance stop to weigh on fourth quarter performance.

Supporting passage from the call, verbatim
“In Fine Chemicals, the bioethanol deliveries are expected to be notably lower than in the fourth quarter of 2025. For fine chemical intermediates, the product mix is expected to be significantly weaker than in the third quarter this year.”

The outlook is not part of the score and not a recommendation to buy or sell.

From the earnings call on 28 Oct 2026 (fiscal Q3 2026), read by AI.

What happened at Borregaard

The key events of the last six months from our own data. A click takes you to the matching card.

Sector comparison

461 rated companies in Basic Materials

Rank 155 of 461
155/ 461
This company
63
Sector median
57

Categories against the sector median

ProfitabilityMedian of 461 companies42 (median 49)7 below the median
GrowthMedian of 461 companies47 (median 54)7 below the median
FundamentalsMedian of 461 companies80 (median 65)15 above the median
ValuationMedian of 421 companies with a value95 (median 69)26 above the median
StabilityMedian of 461 companies82 (median 67)15 above the median
Capital allocationMedian of 461 companies63 (median 52)11 above the median
Technical analysisMedian of 461 companies60 (median 51)9 above the median
MomentumMedian of 461 companies54 (median 50)4 above the median

The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.

Competitors in Chemicals (Specialty)

The next larger and next smaller companies by market value

All 106 Chemicals (Specialty) stocks

ETFs that hold Borregaard

Held by 3 ETFs on Xetra. Shown per index: the ETF with the largest weight.

Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).

Data status and sources

Score
Daily value of 13 Nov 2026, recalculated nightly
Price
Closing price of 12 Nov 2026
Latest annual report
Fiscal year 2025, period end 31 Dec 2025
Currency
Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = NOK 9.5325)
Source
Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.

Mandatory disclosures for this rating

  • ; time horizon around 12 months
  • Rated Neutral, published since 7 Nov 2026 (in the score history since 23 Jan 2026)
  • Valuation signal Undervalued since 7 Nov 2026
  • End-of-day prices, metrics cached for up to 24 hours
  • Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
  • Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
  • Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.

MEQIRI counts visits without cookies. With your consent we remember for 90 days where you came from, also in your account, count page changes and time on page, recognise your next visit and load the Meta Pixel, which measures our advertising. You can withdraw your consent at any time under Cookie settings. Privacy